LANCASTER GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1893-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
20
Active:1
Completed:9
Trial Phases
4 Phases
Phase 1:1
Phase 3:2
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (71.4%)Phase 3
2 (14.3%)Phase 1
1 (7.1%)Phase 4
1 (7.1%)Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
Not Applicable
Recruiting
- Conditions
- Dilated CardiomyopathyHeart FailureHeart Disease
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Lancaster General Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06688396
- Locations
- 🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States
Platelet Transfusion and Repeat TEG-PM in Patients With Severe TBI on Antiplatelet Therapy (Repeat TEG-PM)
- Conditions
- Traumatic Intracranial Hemorrhage
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Lancaster General Hospital
- Target Recruit Count
- 225
- Registration Number
- NCT06433622
- Locations
- 🇺🇸
Penn Medicine Lancaster General Health, Lancaster, Pennsylvania, United States
Parasympathetic Augmentation Via Respiratory Training for Patients With Systolic Heart Failure
Not Applicable
- Conditions
- Diastolic Heart Failure
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Lancaster General Hospital
- Target Recruit Count
- 114
- Registration Number
- NCT05223751
- Locations
- 🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States
The HEALiX™ Intubated Patient (IP) Pilot Study
Not Applicable
Withdrawn
- Conditions
- Device IneffectiveSafety Issues
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2022-01-03
- Lead Sponsor
- Lancaster General Hospital
- Registration Number
- NCT04759066
- Locations
- 🇺🇸
Lancaster General Health, Lancaster, Pennsylvania, United States
The Effect of Melatonin and Vitamin C on COVID-19
Not Applicable
Completed
- Conditions
- Covid19SARS-CoV Infection
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- Lancaster General Hospital
- Target Recruit Count
- 122
- Registration Number
- NCT04530539
- Locations
- 🇺🇸
Lancaster General Health, Lancaster, Pennsylvania, United States
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found